View this email in your browser

This newsletter provides updates from the Hormonal IUD Access Group, a global consortium of governments, donors, manufacturers, procurement agencies, researchers, and service delivery organizations that are collaborating to expand access to the levonorgestrel-releasing intrauterine device (IUD) — also known as the hormonal IUD — in low- and middle-income countries (LMICs) as part of a comprehensive contraceptive method mix.

In this newsletter you will find the following updates:
Learn about the Hormonal IUD at the International Conference on Family Planning 

From November 14-17, global leaders will convene for the International Conference on Family Planning (ICFP) in Pattaya City, Thailand. Check out this listing of presentations and posters that include information about the hormonal IUD. Presentations will include updates about hormonal IUD introduction efforts in Madagascar, Nigeria, Zambia and elsewhere. Highlights are summarized below:
Poster: Implementation of a global learning agenda for the hormonal IUD - Nov 15, 12:30-14:30
Presentation: Perspectives of women at different reproductive life stages and male partners on the hormonal IUD in Zambia - Nov 15, 14:40-16:00
Poster: Increasing efficiencies of reproductive health product introductions through use of best practice guidelines in Nigeria - Nov 16, 12:30-14:30
Panel: What it takes to roll-out a new contraceptive method: Madagascar's first experience with the hormonal IUD - Nov 16, 14:40-16:00
Presentation: Will a digital approach to healthcare provider training work for new FP method introduction in Nigeria? Results from a mixed methods study - Nov 16, 14:40-16:00
Presentation: Evidence from clinical trial data addressing common misconceptions about the hormonal IUD - Nov 17 10:15-11:35
Suppliers of Quality-Assured Hormonal IUD Products Available to Provide Training Support

Both suppliers of quality-assured hormonal IUD products, Bayer and Medicines360, are extending offers to provide support for master trainers to supplement trainings in countries that are actively introducing the method. As key partners in the global effort to increase access to the hormonal IUD, Bayer and Medicines360 have also indicated that they can provide limited donations of demonstration products to support training efforts. If your country is interested in requesting this type of support, please contact the Hormonal IUD Access Group by emailing:
In Case You Missed It: Recent Publications on the Hormonal IUD

What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device
In 2015, a global learning agenda for the hormonal IUD was developed with priority research questions. This review offers a summary of early experiences providing the hormonal IUD in sub-Saharan Africa, as well as lessons from coordination efforts led through the Hormonal IUD Access Group. Download the paper here.

What are the prospects for the hormonal IUD in the public sector? A mixed-method study of the user population in Zambia
A pilot study in Zambia provided insights into why women chose the hormonal IUD, their characteristics, and their experiences with method provision. Download the paper here.

For more information about the Hormonal IUD Access Group, please email:
This email is circulated by members of the global Hormonal IUS Access Group. 
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.


This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Hormonal IUS Access Group · 359 Blackwell St Ste 200 · Durham, NC 27701-2477 · USA

Email Marketing Powered by Mailchimp